630 filings
Page 6 of 32
8-K
5tl y5778pf5ftl9c
13 Jan 21
Other Events
5:01pm
UPLOAD
ii2t7
30 Dec 20
Letter from SEC
12:00am
8-K
07ch0049iksu sm
28 Dec 20
United Therapeutics Announces Agreement to Acquire Priority Review Voucher
6:08am
CORRESP
qf4jua
23 Dec 20
Correspondence with SEC
12:00am
UPLOAD
h0fhcd
15 Dec 20
Letter from SEC
12:00am
8-K
y02kguh azmd1
9 Dec 20
Phase 3 TETON study planned in 2021 for Tyvaso® in patients with idiopathic pulmonary fibrosis
6:00am
8-K
tg9 jjcnu7f2
2 Dec 20
Entry into a Material Definitive Agreement
6:01am
8-K
qfm2asvpguxkjcosu77b
28 Oct 20
United Therapeutics Corporation Reports Third Quarter 2020 Financial Results
6:21am
8-K
a9af2e7q1eb umsl54n
11 Sep 20
United Therapeutics Corporation Appoints Linda Maxwell to Its Board of Directors
6:01am
8-K
0aa2iiqo8q eg
17 Aug 20
Other Events
6:02am
S-8
evnw kcdqs
29 Jul 20
Registration of securities for employees
7:02am
8-K
pmm gdy6lx
29 Jul 20
United Therapeutics Corporation Reports Second Quarter 2020 Financial Results
6:26am
8-K
eom7x5wpl48rnzw
23 Jul 20
United Therapeutics Corporation Asserts New Tyvaso Patent Against Liquidia
6:02am
8-K
e49lfdsq68esmp9
29 Jun 20
Other Events
6:03am
8-K
748c4p
29 Jun 20
Changes in Control of Registrant
12:00am
8-K
9b481n3nm flkre
17 Jun 20
United Therapeutics Announcesincrease Data Presentation at an American Thoracic Society Virtual Session
6:04am
DEFA14A
xq7r525dj320gttd
15 Jun 20
Additional proxy soliciting materials
5:28pm
8-K
n84k9ncuy66fu
5 Jun 20
United Therapeutics Corporation Files Lawsuit Against Liquidia for Infringement of Tyvaso Patents
6:01am